Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
126959651 | 12695965 | 1 | I | 201512 | 20160822 | 20160829 | 20160829 | EXP | ES-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2016-BI-56314BY | BOEHRINGER INGELHEIM | 47.00 | YR | M | Y | 0.00000 | 20160830 | CN | ES | ES |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
126959651 | 12695965 | 1 | PS | MICARDIS | TELMISARTAN | 1 | Unknown | 40 MG | U | 20850 | 40 | MG | TABLET | QD |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
126959651 | 12695965 | 1 | Hypertension |
Outcome of event
Event ID | CASEID | OUTC COD |
---|---|---|
126959651 | 12695965 | OT |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
126959651 | 12695965 | Arthralgia | |
126959651 | 12695965 | Choking | |
126959651 | 12695965 | Cough | |
126959651 | 12695965 | Hyperhidrosis | |
126959651 | 12695965 | Myalgia | |
126959651 | 12695965 | Rash macular |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
---|---|---|---|---|---|---|
126959651 | 12695965 | 1 | 201509 | 0 |